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Abstract
Objective—Posttraumatic stress disorder (PTSD) and depression are common after evaluation 
for suspected acute coronary syndrome (ACS), and are associated with poor prognosis. However, 
it is unclear whether patients discharged after suspected ACS access treatments for subsequent 
psychological distress. We examined self-reported rates of receiving psychotherapy and/or 
medication for psychological distress in patients one month after a suspected ACS event.
Methods—A sample of 448 adults (age 60.4±12.5; 47.8% female; 52.7% Hispanic, 32.1% 
Black) presenting to the emergency department with suspected ACS were recruited for the 
REactions to Acute Care and Hospitalization (REACH) study, an ongoing cohort study of medical 
and psychological outcomes after ACS evaluation. Socio-demographics and depressive symptoms 
were assessed in-hospital, and PTSD symptoms related to the suspected ACS event were queried 
via phone one month after enrollment. Participants also indicated whether they received either 
medication or counseling to deal with their emotions and coping after their heart problem.
Results—Approximately 15% (n=68) of the sample reported receiving some form of treatment. 
Treatment rate did not differ significantly as a function of demographics, ACS status, or insurance 
coverage, ps>0.1. Over a quarter of participants (25.3%) who screened positive for PTSD and/or 
depression reported receiving treatment. Participants with PTSD and depression had a higher 
treatment rate (47.6%) vs. those with only depression (12.8%) or PTSD (30%) or no 
psychopathology (10.3%).
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Conclusion—Findings suggest that 1 in 4 patients who screened positive for PTSD and/or 
depression reported receiving counseling or medication in the first month after a suspected ACS 
event.
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Introduction
Posttraumatic stress disorder (PTSD) and depression are associated with both incident and 
recurrent cardiovascular events and mortality (Edmondson et al. 2012; Edmondson et al., 
2013; Van der Kooy et al., 2007; Van Melle, 2004), and both are common after acute 
coronary syndrome (ACS) events. Approximately 12% of ACS patients develop PTSD due 
to the event (Edmondson et al., 2012), and 20% are depressed (Freedland et al. 2003). 
Established psychotherapeutic and pharmacological treatments exist (Hollon et al., 2002; 
Institute of Medicine, 2008), but it is unclear whether patients discharged after suspected 
ACS events access them. Although information on mental health treatment rates for cardiac 
patients is generally lacking in the literature, the extant evidence suggests that psychological 
conditions like depression and PTSD are generally undertreated. For example, in one study 
of cardiac patients, only 11% of those with depression received appropriate treatment with 
antidepressants (Huffman et al., 2006). Furthermore, findings from the broader PTSD 
literature suggest that over 50% of individuals with PTSD that develops in response to a 
variety of traumas never receive treatment (Roberts et al., 2011). In particular, treatment 
rates may be low among low socioeconomic status (SES), racial/ethnic minority patients 
(Ghafoori et al. 2014; Roberts et al., 2011). We examined self-reported rates of receiving 
psychotherapy and medication for psychological distress in patients one month after a 
suspected ACS event, and compared rates across demographic and mental health categories.
Method
Sample
English- and Spanish-speaking participants were enrolled during evaluation for suspected 
ACS in the emergency department (ED) at New York-Presbyterian Hospital as part of the 
REactions to Acute Care and Hospitalization (REACH) study, an ongoing observational 
cohort study of ED predictors of medical and psychological outcomes after evaluation for 
suspected ACS (Sumner et al., 2015). Potential participants were identified by a provisional 
diagnosis of “probable ACS” by the treating ED physician. Exclusion criteria included: ST 
elevations on an electrocardiogram; unable to follow the protocol (due to dementia or 
substance abuse); in need of immediate psychiatric intervention; and unavailable for follow-
up (e.g., due to terminal non-cardiovascular illness). This study was approved by the 
Institutional Review Board at Columbia University Medical Center; all participants provided 
written informed consent. The analytic sample comprised 448 patients (age 60.4 ± 12.5; 
47.8% female; 52.7% Hispanic, 32.1% Black, 65% with HS Diploma or above) with 
complete data.
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In the ED, participants reported on socio-demographics. Once transferred to an inpatient bed 
(or via telephone if inpatient interview was not possible), participants were administered the 
Patient Health Questionnaire (PHQ; Kroenke et al., 2001) to assess past 2-week depressive 
symptoms. Diagnosis at discharge was determined by review of the medical record by a 
board-certified cardiologist. One month after ED enrollment, participants completed the 
PTSD Checklist-Stressor Specific version (PCL-S; Weathers et al., 1993) via telephone, 
which queried PTSD symptoms in response to the “heart problem, ED visit, and 
hospitalization” that occurred when they enrolled in the study. During this interview, they 
also indicated if they received either medication or counseling “to deal with your emotions 
and coping after your heart problem” (i.e., the event that prompted their enrollment in the 
study). Participants were not provided with treatment recommendations or referrals by study 
personnel as part of the study.
Analytic Approach
We computed rates of self-reported receipt of treatment in the full sample. Additionally, chi-
square or t-tests were used to test for differences in reported treatment rates as a function of 
demographics, ACS status, and health insurance coverage. We examined whether receiving 
treatment differed as a function of psychopathology by comparing treatment rates in 
participants who screened positive for depression at inpatient interview (PHQ score≥10; e.g., 
Kroenke et al., 2001), PTSD at 1-month follow-up (PCL-S score≥34; e.g., Bliese et al., 
2008), or both using chi-square tests.
Results
Approximately 15% of the entire sample (n=68) reported receiving some form of treatment. 
A total of 28 (6.3%) individuals reported receiving counseling, 16 (3.6%) individuals 
reported receiving medication, and 24 (5.4%) individuals reported receiving both. There 
were no significant differences in treatment rate as a function of demographics, ACS status, 
or insurance coverage (ps >0.1), see Table 1.
Thirty-three percent of the sample (N=146) screened positive for depression, PTSD, or both. 
Of those, 25% reported receiving some type of treatment, with 8.2% receiving counseling, 
6.9% taking medication, and 10.3% receiving both. Of the 116 (26%) participants who 
screened positive for depression at the inpatient interview, 28 (24%) reported receiving some 
treatment. Of the 68 (16.4%) who screened positive for PTSD at one month, 27 (40%) 
reported receiving some treatment. There was a significant difference in treatment rates 
between the no psychopathology, depression only, PTSD only, and comorbid depression and 
PTSD groups (χ2=41.7, df=3, p<0.0001). Participants with comorbid depression and PTSD 
had a higher reported treatment rate (47.6%) compared to those with only depression 
(12.8%) or PTSD (30%) or no psychopathology (10.3%).
Discussion
PTSD and depression are common after acute cardiac events (e.g., Edmondson et al., 2012; 
Freedland et al., 2003). Generally little research has been published addressing mental health 
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treatment rates for cardiac patients, but the few existing studies suggest that these patients 
are frequently undertreated (e.g., Hoffman et al., 2006). This report is among the first to 
consider treatment rates for emotional distress after evaluation for suspected ACS. Our 
sample comprised patients evaluated for suspected ACS with relatively low SES and diverse 
racial/ethnic identification. These results suggest that a relatively high proportion of patients 
report receiving some form of mental health treatment. Specifically, 1 in 4 (25.3%) of those 
who screened positive for a psychological disorder reported receiving counseling or 
medication in the first month after the suspected event, with no significant differences across 
demographic groups. Interestingly, approximately 10% of those without probable PTSD or 
depression reported receiving treatment as well. Treatment in this group might reflect 
successful treatment of symptoms or indicate prophylactic seeking of assistance for 
emotional issues in the acute aftermath of a potentially life threatening medical event. 
Additional research is needed to better understand motivations behind receiving such 
treatment in this patient population. It is also of interest for future research to develop a 
more nuanced understanding of potential mental health treatment opportunities that are 
available for patients after evaluation for suspected ACS, as well as patients’ level of interest 
in such treatment.
Limitations
The sample comprised patients evaluated for ACS in the ED, and a majority subsequently 
received a non-ACS discharge diagnosis. Receiving treatment was identified by patient 
report, and was not compared to electronic medical records. Half of the sample was Hispanic 
and most reported low SES, so these results do not reflect treatment receipt rates for the 
population of all suspected ACS patients.
Conclusions
PTSD and depression after cardiac events have been associated with poor prognosis. This 
study suggests that 25% of low SES, racially/ethnically diverse patients in an urban setting 
who screen positive for one or both disorders may receive treatment. Currently, evidence 
demonstrating that treatment improves cardiovascular prognosis is limited, but this is a 
heartening finding nonetheless and should be replicated with medical records in more 
diverse samples.
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• PTSD and depression are common after evaluation for suspected acute 
coronary syndrome (ACS)
• Research on treatment rates for subsequent emotional distress after 
discharge for ACS is lacking
• Findings suggest 1 in 4 patients with PTSD and/or depression report 
receiving treatment after ACS
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Table 1

















(25% of those with
psychopathology)








Age 59.7±10.9 60.6±12.8 59.6±11.8 59.0±11.4
Female sex 45.6 (31) 48.2 (183) 52.1 (76) 40.5 (15)
Black race 33.8 (23) 31.8 (121) 28.1 (41) 21.6 (8)
Hispanic ethnicity 50.0 (34) 51.6 (196) 56.2 (82) 46.0 (17)
> HS education 58.2 (39) 66.1 (252) 58.2 (85) 54.1 (20)
Insured 85.3 (58) 86.6 (329) 85.6 (125) 78.4 (29)
Confirmed ACS 25.0 (17) 35.3 (134) 33.6 (49) 27.0 (10)
Note. HS=high school. ACS=acute coronary syndrome.
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